Morten A Karsdal Selected Research

farglitazar

1/2022	An MMP-degraded and cross-linked fragment of type III collagen as a non-invasive biomarker of hepatic fibrosis resolution.
1/2019	Assessment of liver fibrosis progression and regression by a serological collagen turnover profile.
12/2016	Fibrogenesis assessed by serological type III collagen formation identifies patients with progressive liver fibrosis and responders to a potential antifibrotic therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Morten A Karsdal Research Topics

Disease

44	Fibrosis (Cirrhosis) 03/2022 - 10/2010
29	Bone Resorption 12/2021 - 11/2003
28	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022 - 10/2010
26	Osteoarthritis 01/2022 - 07/2005
25	Inflammation (Inflammations) 12/2021 - 12/2011
17	Neoplasms (Cancer) 04/2022 - 07/2006
16	Disease Progression 01/2022 - 12/2006
12	Rheumatoid Arthritis 01/2021 - 05/2008
12	Chronic Obstructive Pulmonary Disease (COPD) 11/2020 - 01/2012
10	Insulin Resistance 12/2021 - 07/2013
10	Pain (Aches) 01/2021 - 12/2011
10	Type 2 Diabetes Mellitus (MODY) 01/2020 - 08/2009
8	Osteopetrosis 07/2014 - 11/2005
7	Obesity 01/2022 - 07/2013
7	Liver Diseases (Liver Disease) 12/2021 - 08/2011
7	Weight Loss (Weight Reduction) 12/2021 - 07/2014
7	Idiopathic Pulmonary Fibrosis 11/2021 - 01/2012
7	Knee Osteoarthritis 01/2021 - 01/2009
6	Crohn Disease (Crohn's Disease) 12/2022 - 01/2020
6	Non-alcoholic Fatty Liver Disease 04/2022 - 01/2019
6	Body Weight (Weight, Body) 01/2021 - 07/2013
6	Breast Neoplasms (Breast Cancer) 08/2019 - 07/2006
6	Atherosclerosis 01/2013 - 11/2009
5	Ankylosing Spondylitis 12/2022 - 11/2012
5	Portal Hypertension 11/2022 - 08/2011
5	Fatty Liver 04/2022 - 01/2017
5	Joint Diseases (Joint Disease) 01/2021 - 05/2008
5	Necrosis 01/2019 - 01/2008
5	Osteoporosis 01/2017 - 07/2004
4	Systemic Scleroderma (Systemic Sclerosis) 04/2020 - 10/2015
4	Rheumatic Diseases (Rheumatism) 01/2019 - 04/2011
4	Atherosclerotic Plaque (Atheroma) 02/2012 - 04/2010
3	Pancreatic Neoplasms (Pancreatic Cancer) 02/2022 - 11/2013
3	Cicatrix (Scar) 02/2021 - 01/2019
3	Chronic Renal Insufficiency 02/2021 - 03/2016
3	Synovitis 01/2021 - 01/2017
3	Pathologic Processes 11/2020 - 12/2011
3	Emphysema 01/2020 - 01/2017
3	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 01/2013
3	Wounds and Injuries (Trauma) 01/2018 - 01/2002
3	Hyperglycemia 01/2017 - 12/2011

Drug/Important Bio-Agent (IBA)

109	Biomarkers (Surrogate Marker)IBA 12/2022 - 07/2006
58	CollagenIBA 12/2022 - 02/2008
30	Matrix Metalloproteinases (MMPs)IBA 01/2022 - 01/2002
29	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2005
23	Collagen Type III (Type III Collagen)IBA 03/2022 - 10/2010
20	Complement C3 (C3 Complement)IBA 02/2022 - 01/2013
15	Collagen Type I (Type I Collagen)IBA 04/2022 - 07/2006
15	EpitopesIBA 01/2022 - 07/2006
14	Pharmaceutical PreparationsIBA 04/2022 - 07/2008
12	Glucose (Dextrose)FDA LinkGeneric 12/2021 - 12/2011
10	C-Reactive ProteinIBA 12/2022 - 10/2012
10	Peptides (Polypeptides)IBA 04/2022 - 08/2011
10	CalciumIBA 10/2016 - 09/2007
9	Collagen Type IV (Type IV Collagen)IBA 12/2022 - 10/2011
9	Peptide Hydrolases (Proteases)FDA Link 01/2022 - 04/2010
9	Collagen Type VIIBA 01/2022 - 01/2017
9	Insulin (Novolin)FDA Link 01/2017 - 08/2009
8	Collagen Type II (Type II Collagen)IBA 01/2022 - 09/2005
8	ImmunosorbentsIBA 01/2022 - 10/2010
8	EnzymesIBA 01/2022 - 10/2010
8	catch-relaxing peptide (Mytilus)IBA 01/2021 - 02/2014
8	Metalloproteases (Metalloproteinases)IBA 05/2019 - 04/2011
7	Carbon Tetrachloride (Tetrachloromethane)IBA 03/2013 - 03/2011
6	collagen type I trimeric cross-linked peptideIBA 01/2022 - 07/2006
6	Islet Amyloid PolypeptideIBA 12/2021 - 09/2015
6	Calcitonin Receptors (Calcitonin Receptor)IBA 12/2021 - 09/2015
6	VimentinIBA 01/2021 - 04/2013
6	salmon calcitonin (Calcimar)FDA LinkGeneric 01/2019 - 09/2005
6	ElastinIBA 01/2017 - 10/2010
6	Cathepsin KIBA 10/2012 - 11/2003
5	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 01/2021 - 01/2006
5	Biological ProductsIBA 05/2019 - 12/2011
4	endotrophinIBA 01/2022 - 01/2017
4	Aggrecans (Aggrecan)IBA 01/2022 - 05/2008
4	KBP-042IBA 12/2021 - 07/2014
4	OsteocalcinIBA 11/2021 - 02/2014
4	Extracellular Matrix ProteinsIBA 06/2021 - 01/2015
4	Hormones (Hormone)IBA 07/2020 - 05/2013
4	Oncostatin MIBA 01/2019 - 01/2008
4	Versicans (Versican)IBA 10/2018 - 01/2013
4	CytokinesIBA 01/2018 - 05/2013
4	Collagen Type V (Type V Collagen)IBA 01/2016 - 08/2011
4	AcidsIBA 07/2014 - 09/2008
4	Adenosine Triphosphatases (ATPase)IBA 09/2012 - 10/2007
3	Complement C4 (Complement Component 4)IBA 11/2022 - 01/2020
3	farglitazarIBA 01/2022 - 12/2016
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 10/2012
3	tocilizumab (atlizumab)FDA Link 01/2021 - 10/2012
3	von Willebrand FactorIBA 07/2020 - 08/2019
3	Proteoglycans (Proteoglycan)IBA 01/2020 - 10/2010
3	Blood Glucose (Blood Sugar)IBA 01/2020 - 08/2014
3	Indicators and Reagents (Reagents)IBA 08/2019 - 07/2006
3	PPAR gammaIBA 03/2019 - 08/2009
3	Matrix Metalloproteinase InhibitorsIBA 01/2019 - 01/2002
3	N- (2(R)- 2- (hydroxamidocarbonylmethyl)- 4- methylpentanoyl)- L- tryptophan methylamideIBA 01/2019 - 06/2010
3	balaglitazoneIBA 01/2017 - 05/2011
3	Alanine Transaminase (SGPT)IBA 12/2016 - 03/2013

Therapy/Procedure

18	Therapeutics 10/2021 - 05/2011
5	Ligation 01/2018 - 08/2011